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From the Editor’s Desk
AUSTRALIA'S NATIONAL 
RESEARCH PRIORITIES
Our politicians are mostly a pragmatic lot; 
visions are not their style. However, our 
Prime Minister had a vision about 3 years 
ago, which was “to deliver the kind of future 
that we want” through enactment of four 
national research priorities (NRPs).
Following his announcement, the NRP 
fish were away and swimming upstream to 
spawn. One hatchling is Promoting and 
maintaining good health, which comprised 
the following priority goals: A healthy start to 
life; Ageing well, ageing productively; 
Preventive health care; and Strengthening 
Australia’s social and economic fabric. Now, 
almost 3 years later, the hatchlings are in 
danger of falling victim to the exhausting 
bureaucratic currents, and their fate may 
well be to float downstream into the oceans 
of irrelevance. 
Our research agencies, the National Health 
and Medical Research Council and the 
Australian Research Council, are currently 
working together on the priority goal, 
Ageing well, ageing productively, but despite 
a plethora of preceding relevant reports, 
progress is slow.
Ironically, the process to develop 
Australia’s NRPs started in the same month 
(May 2002) that Elias Zerhouni, the new 
director of the United States National 
Institutes of Health (NIH), announced 
his vision to develop the NIH’s road map 
for the 21st century. 
In September 2003, the NIH released 
details of its turbo-charged plan, “to 
transform US medical research and speed 
up the movement of research from bench 
to bedside”. Across the border, Canada has 
also developed its blueprint for health 
research and innovation.
And all the while, the bureaucratic 
carousel in Canberra goes round and round. 
In February this year, the NRPs’ carousel 
acquired a new operator — a supervisory 
committee, established some 3 years after 
the original “vision” was announced! 
Apropos this breathtaking languidness, 
most Australians have every right to know 
what in the world is going on! After all, 
ageing waits for no one.
Martin B Van Der Weyden
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Letters
Which medicines do young 
children access from blister 
packs?
Elizabeth A Hender,* Corrine R Balit†
*Scientific Officer, Hazardous Substances Section, 
Environmental Health Service, Department of Health, 
PO Box 6 Rundle Mall, Adelaide, SA 5000; †Research 
Pharmacist, New South Wales Poisons Information 
Centre, The Children’s Hospital, Westmead, NSW. 
elizabeth.hender@health.sa.gov.au
TO THE EDITOR: Although there are few
deaths due to poisoning in Australian chil-
dren, from 1993 to 1997 there was an
average of more than 2500 admissions to
hospital per year for assessment of poison-
ing with medicines in children younger than
5 years.1
Child-resistant packaging has been effec-
tive in preventing accidental poisoning with
prescription medicines and aspirin in young
children in the United States.2,3 In the US,
both reclosable and non-reclosable (blister
or strip) packaging used for pharmaceuticals
required to be in child-resistant packaging is
tested to confirm its effectiveness in prevent-
ing access by children.4 In Australia, only
reclosable packaging is required to be child-
tested. Blister or strip packaging, which has
not usually been child-tested, is accepted as
an alternative to child-resistant reclosable
packaging.5
We conducted a study at the New South
Wales Poisons Information Centre
(NSWPIC) over 9 weeks from 18 July to 17
September 2003. Our aims were to ascertain
which medicines children younger than 5
years access directly from blister or strip
packaging, and whether assessment at a
hospital was recommended. The study was
approved by the Ethics Committee of the
Children’s Hospital, Westmead.
Callers ringing about a suspected acciden-
tal ingestion of a solid dose medicine in a
child younger than 5 years were asked
whether the child accessed the medicine
directly from a blister or strip pack. There
were 318 accidental exposures to solid dose
medicines in these children during the study
period. In 186 exposures (58%), the caller
said the medicine was normally in a blister
or strip pack and the child obtained it
directly from the pack.
 A wide range of medicines (40 different
drugs or drug groups) were associated with
the exposures; the most common were oral
contraceptives (49 exposures) and paraceta-
mol (27 exposures). Some of the exposures
involved medicines that can cause severe
toxicity when children ingest a small
number of dose units, such as clonidine,
olanzapine, narcotic analgesics, and tricyclic
antidepressants.
In 36 exposures where the child obtained
the medicine directly from the pack, the
caller was advised to take the child to
hospital (Box). Many of the medicines asso-
ciated with these exposures (eg, paraceta-
mol, preparations containing narcotic
analgesics, antidepressants, antihistamines,
iron and clonidine) are required to be in
child-resistant packaging.5
Our study shows that blister or strip
packs currently in use did not prevent chil-
dren accessing drugs. This finding calls into
question whether blister or strip packaging
that has not been child-tested presents an
adequate safety barrier.
No outcomes of drug ingestion are known
in this study, which is a limitation. However,
assessment of these children in hospital
represents a financial burden to the health
care system regardless of the outcome. Fur-
ther studies would be required to quantify
the harm associated with exposures to med-
ications packaged in blister or strip packag-
ing in young children and to assess the
effectiveness of such packaging in the pre-
vention of poisoning.
Acknowledgement:  The support of Judith Kirby
and the specialists in poisons information at the
NSWPIC is gratefully acknowledged.
1 O’Connor P. Accidental poisoning of preschool
children from medicinal substances, Australia. Injury
Research and Statistics Series No. 9. Adelaide:
Australian Institute of Health and Welfare, 2002.
(AIHW Catalogue No. INJCAT39.) Available at:
http://www.nisu.flinders.edu.au/pubs/reports/2001/
injcat39.pdf (accessed Nov 2004).
2 Rodgers GB. The safety effects of child-resistant
packaging for oral prescription drugs. Two decades
of experience. JAMA 1996; 275: 1661-1665.
3 Rodgers GB. The effectiveness of child-resistant
packaging for aspirin. Arch Pediatr  Adolesc Med
2002; 156: 929-933.
4 United States Consumer Product Safety Commis-
sion. Testing procedure for special packaging. In:
Federal Regulations Associated with the Poison
Prevention Packaging Act. Title 16 CFR Part
1700.20. Available at: http://www.access.gpo.gov/
nara/cfr/waisidx_04/16cfr1700_04.html (accessed
Nov 2004).
5 Therapeutic Goods Order No. 65. Child-resistant
packaging for therapeutic goods. Canberra: Com-
monwealth of Australia, 2004. Available at: http://
www.tga.gov.au/docs/html/tgo/tgo65.htm
(accessed November 2004). ❏
Low-carbohydrate diets in 
Australia: prevalence and 
public perceptions
Timothy C Crowe,* 
David Cameron-Smith†
*Lecturer, †Senior Lecturer, School of Exercise 
and Nutrition Sciences, Deakin University, 
Burwood, VIC 3125. tcrowe@deakin.edu.au
TO THE EDITOR: Low-carbohydrate diets
have re-emerged into the public spotlight
and are enjoying widespread popularity.
However, current evidence indicates that
low-carbohydrate diets have no significant
advantage over more traditional energy-
restricted diets for long-term weight loss and
maintenance.1-3 While these diets have
shown short-term efficacy in modifying
some lipid parameters and measures of insu-
lin sensitivity, questions remain about the
risk of adverse effects with long-term carbo-
hydrate restriction.4
The scientific literature has not addressed
the questions of how the general public
perceive these diets, and what dieting
approaches they adopt. Dieting perceptions
and practices within the community may be
far removed from the strictly controlled
situation of published research.
A national telephone survey of 1200
adults aged 18 years and over was con-
ducted by the private market research com-
pany Newspoll from 6 to 8 August 2004.
The survey asked about knowledge of and
attitudes to carbohydrates and dieting. Tele-
phone numbers were randomly selected,
with a quota for capital city and non-capital
city areas. Selection of an individual in each
household was based on the last birthday.
Response rate to the survey was 11%. Sex,
age, marital status and working status
demographics were representative of the
Australian adult population.
Drugs accessed from blister or strip 
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The main findings are summarised in
the Box. Most of those surveyed correctly
identified foods such as pasta and bread as
“carbohydrate foods”. Only a third of peo-
ple identified soft drinks and lollies as
carbohydrate foods, and 20% incorrectly
identified cheese and eggs as carbohydrate
foods. Almost 17% of people had either
tried, or intended to try, a low-carbohy-
drate diet, with women more likely to have
tried this diet. Half of those surveyed
believed that carbohydrate foods should
make up a quarter or less of the daily diet
(current health recommendations are that
about half the diet should comprise carbo-
hydrates). Almost 70% of those surveyed
believed they needed to cut back on carbo-
hydrates to lose weight.
Based on this survey, low-carbohydrate
dieting practices are as widespread in Aus-
tralia as in the United States.5 Interestingly,
the US study noted a greater propensity to
use carbohydrate-reduced diets among
those who were obese, had diabetes, hyper-
tension or high cholesterol.
Our data demonstrated widespread mis-
understanding of what constitutes a high-
carbohydrate food, which may leave many
individuals at risk of choosing a diet that
selectively excludes wholegrain foods, fruits
and some dairy products. Health profession-
als should be aware that low-carbohydrate
diets remain popular, that the people who
are following these diets may represent a
more “at risk” population, and that the food
choices made by those following this dietary
pattern may have adverse long-term health
effects.
Competing interests:  The Newspoll survey was
commissioned by GoGrains (a nutrition communi-
cation initiative established for the Australian
grains industry). The complete and unedited
results from the survey were provided to the
authors by GoGrains for independent analysis and
scientific reporting without restriction. The authors
were not involved in designing or conducting the
survey, and have no commercial or personal rela-
tionship with GoGrains or the Australian grains
industry.
1 Wyatt HR, Seagle HM, Grunwald GK, et al. Long-
term weight loss and very low carbohydrate diets.
Obes Res 2000; 8 Suppl 1: 87S.
2 Stern L, Iqbal N, Seshadri P, et al. The effects of low-
carbohydrate versus conventional weight loss diets
in severely obese adults: one-year follow-up of a
randomized trial. Ann Int Med 2004; 140: 778-785.
3 Foster GD, Wyatt HR, Hill JO, et al. A randomized
trial of a low-carbohydrate diet for obesity. N Eng J
Med 2003; 348: 2082-2090.
4 Bilsborough SA, Crowe TC. Low-carbohydrate
diets. What are the long-term health implications?
Asia Pac J Clin Nutr 2003; 12: 396-404.
5 NPD Foodworld. Carbohydrate consumption pat-
terns. Rosemont, Ill: The NPD Group Inc, 2004.
Available at: http://www.npdfoodworld.com/food-
Servlet?nextpage=pr_body.html&content_id=865
(accessed Dec 2004). ❏
Tramadol and seizures
Ian W Boyd
Executive Officer, Adverse Drug Reactions Unit, 
Therapeutic Goods Administration, 
Australian Government Department of Health 
and Ageing, PO Box 100, Woden, ACT 2606.
ian.boyd@health.gov.au
TO  THE E DITOR: Labate and colleagues
note that tramadol is the most frequently
suspected cause of provoked seizures at
their First Seizure Clinic.1
Early in 2003, the Adverse Drug Reac-
tions Advisory Committee (ADRAC)
reported to Australian prescribers the results
of the first 4 years of experience with trama-
dol in Australia.2 At the time, ADRAC noted
that 26 cases of convulsions had been
reported among a total of 354 reports on
tramadol.
By January 2005, ADRAC had received a
total of 921 reports involving tramadol, of
which 66 described convulsions. (Labate et
al reported that 83 cases of convulsions
associated with tramadol had been reported
to ADRAC. This is incorrect, but the mistake
probably resulted from an error in interpre-
tation of information supplied by the
Adverse Drug Reactions Unit.) In 27 cases,
tramadol was the only suspected drug, but
in the other 39 cases there were various
other suspected drugs. This included 20
reports in which there was a suspected drug
interaction. Both oral and injected tramadol
have been implicated.
The product information for tramadol
states that convulsions have been reported
in patients using tramadol at the recom-
mended dose levels and that the risk may be
greater when doses of tramadol exceed the
recommended limits.3 In addition, tramadol
may increase the seizure risk in patients
taking other medications that lower the
seizure threshold. Drugs specifically men-
tioned in this context include the selective
serotonin reuptake inhibitors, tricyclic anti-
depressants and antipsychotic drugs. In the
39 cases reported to ADRAC in which there
were one or more suspected drugs in addi-
tion to tramadol, tramadol was being used
with selective serotonin reuptake inhibitors
(10 cases), tricyclic antidepressants (6 cases)
and, in 13 cases, other drugs that may also
have the potential to lower the seizure
threshold, such as pethidine (2 cases), ven-
lafaxine (2), propofol (2) and bupropion (2).
In two of the cases in which tramadol was
the only suspected cause and two of the
cases with multiple suspected causes, the
patients were also taking anticonvulsant
drugs for seizure control.









Which of the following foods, if any, do you regard as 
carbohydrate foods?
Bread 89% 85% 93%
Pasta 90% 88% 93%
Rice 80% 76% 83%
Breakfast cereal 79% 77% 80%
Lollies 35% 36% 35%
Soft drink 34% 31% 36%
Cheese 20% 22% 19%
Eggs 18% 20% 16%
Have you tried or do you intend to try the Atkins diet, 
or some other low-carbohydrate diet?
17% 11% 22%
Based on official recommended guidelines for a healthy diet, 
about how much of a person’s diet should be made up of 
foods such as bread, breakfast cereal, pasta and rice?
Less than a quarter 7% 7% 7%
About a quarter 43% 34% 51%
About half 29% 31% 26%
About three quarters 6% 8% 4%596 MJA • Volume 182 Number 11 • 6 June 2005
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ADRAC data indicate that, although tra-
madol alone can induce seizures, these are
more likely to occur in the setting of the
concomitant use of other drugs that also
have the potential to lower the seizure
threshold.
1 Labate A, Newton MR, Vernon GM, Berkovic SF.
Tramadol and new-onset seizures [letter]. Med J
Aust 2005; 182: 42-43.
2 Adverse Drug Reactions Advisory Committee. Tra-
madol – four years’ experience. Aust Adverse Drug
React Bull 2003; 22: 2.
3 Tramal product information. Melbourne: CSL Lim-
ited, 27 November 2002. ❏
Bedwetting and toileting 
problems in children
Graham R Wicks
Medical Hypnotherapist, Department of Psychological 
Medicine, Women’s and Children’s Hospital, 
North Adelaide; 9 Collins Street, Collinswood, 
SA 5081. grwicks@bigpond.net.au
TO THE EDITOR: I was interested to read
the article about managing nocturnal enu-
resis in children,1 but was surprised and
disappointed that there was no mention of
the place of medical hypnotherapy.
Hypnotherapy can be particularly valua-
ble in the treatment of monosymptomatic
nocturnal enuresis in children aged from 7
or 8 years upwards, and has the advantage
of being completely non-invasive with no
side effects. It focuses on empowering the
children to take control of their own bodily
functions.2
Hypnotherapy is also of value in the
management of nocturnal enuresis associ-
ated with day-time symptoms, such as
urgency with or without incontinence, and
can also be used to enhance the efficacy of
treatments like enuresis alarm systems.
While there are few well documented
comparative studies3 on the benefits of hyp-
nosis versus other treatments for nocturnal
enuresis, there are numerous anecdotal
reports and studies involving a series of
patients being successfully treated with hyp-
notherapy.
Hypnosis should only be used by prop-
erly trained doctors or psychologists who
have access to the full range of medical
investigations.
Hypnosis is of course not a panacea, but is
an excellent first-choice treatment for mono-
symptomatic nocturnal enuresis, the com-
monest type seen by general practitioners.
If, after three or four treatment sessions,
hypnosis is not effective, other approaches
can be employed.
A quick search of the internet using the
terms “enuresis and hypnotherapy” will
reveal over 700 sites with information on
the subject, and there are several highly
respected professional journals that pub-
lish clinical and research papers and arti-
cles on the use of hypnosis in medicine and
psychology. All of these are published by
reputable professional societies whose
membership is limited to registered health
professionals.
The Australian Society of Hypnosis (http://
www.ozhypnosis.com.au) conducts ongoing
training courses in all states of Australia for
graduates in medicine, psychology and den-
tistry.
Hypnotherapy is now becoming more
and more accepted worldwide as a valuable
and legitimate tool that can be used, in
conjunction with the more traditional
approaches, in a wide variety of medical and
psychological problems.
It is a great pity that many clinicians are
either not aware of its value or are still loathe
to accept it because of negative connotations
associated with its use for entertainment
purposes and in the hands of non-profes-
sional therapists.
1 Caldwell PHY, Edgar D, Hodson E, Craig JC. 4.
Bedwetting and toileting problems in children.
Med J Aust 2005; 182: 190-195.
2 Olness K. The use of self-hypnosis in the treat-
ment of childhood nocturnal enuresis: A report
on 40 patients. Clin Pediatr (Phila) 1975; 14:
273-275, 278-279.
3 Banerjee S, Srivastav A. Hypnosis and self-
hypnosis in the management of nocturnal enu-
resis: a comparative study with imipramine. Am
J Clin Hypn 1993; 36: 113-119. ❏
Patrina HY Caldwell,* Denise Edgar,† 
Elisabeth Hodson,‡ Jonathan C Craig§
*Staff Specialist and Lecturer, †Head, Department 
of Nephrology, §Associate Professor and Head 
of Clinical Research, NHMRC Centre of Clinical 
Research Excellence in Renal Medicine, The 
Children’s Hospital at Westmead, Locked Bag 4001, 
Westmead, Sydney, NSW 2145; ‡Clinical Nurse 
Consultant, The Continence Foundation of Australia 
in NSW, Sydney, NSW. Patrinac@chw.edu.au
IN  REPLY: Thank you for your interesting
comments regarding hypnotherapy in the
treatment of nocturnal enuresis in children.
There are a number of therapies, such as
hypnotherapy, electrotherapy and acupunc-
ture, which show great promise for the
management of nocturnal enuresis. We only
included in our article1 treatments that were
supported by evidence from well docu-
mented comparative studies. Using compre-
hensive search strategies, we have not found
comparative studies for these complemen-
tary therapies.
We would be very interested to be
directed to studies that have formally evalu-
ated other interventions. There is a huge
need for randomised controlled trials com-
paring alternative treatment strategies with
conventional therapy in this area.
1 Caldwell PHY, Edgar D, Hodson E, Craig JC. 4.
Bedwetting and toileting problems in children.
Med J Aust 2005; 182: 190-195. ❏
Genetic risk estimation by 
health care professionals
Edwin P Kirk,* Annette Hattam,† 
Anne Turner‡
*Co-ordinator of Advanced Training, †Chair, 
Specialist Advisory Committee in Clinical Genetics, 
Royal Australasian College of Physicians; and 
Geneticists, Department of Medical Genetics, Sydney 
Children’s Hospital, High Street, Randwick, NSW 2031; 
‡Chairperson, Board of Censors in Genetic Counsel-
ling, Human Genetics Society of Australasia. 
kirked@sesahs.nsw.gov.au
TO THE EDITOR: Genetic risk estimation
is a key element of the practice of clinical
geneticists and genetic counsellors. Given
this, it was with some concern that we read
the findings of Bonke and colleagues regard-
ing the performance of (mainly European)
geneticists and counsellors in the applica-
tion of Bayesian analysis to risk estimation.1
Bayesian analysis is taught as part of
Australasian training in both clinical genet-
ics and genetic counselling, and has been for
as long as there have been formal programs.
Thus, most Australian geneticists and coun-
sellors should be familiar with the applica-
tion of Bayes’ theorem to risk estimation.
In actual clinical practice, it is rare to need
to perform this type of analysis. This is partly
because of the rapid progress in molecular
genetic testing, which often obviates the
need for such calculations, and partly
because situations in which Bayesian analysis
is clinically helpful are uncommon. Pedi-
grees like those in the study by Bonke et al
do not come along often; when they do, the
modification of prior risk by Bayesian analy-
sis is not often important. For example,
modification of a risk from 50% to 33% or
from 25% to 17% (as in two of the examples
used by Bonke et al) is unlikely to alter
decision-making for the families involved.
Specifically, as these examples all involve
testing for Huntington’s disease, in which
molecular analysis is usually quite straight-
forward, we would expect very few individu-MJA • Volume 182 Number 11 • 6 June 2005 597
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als would decide whether to proceed with
testing based on being given information
about modification of risk expressed this
way.
Moreover, when you are not performing
this type of calculation regularly, it is time-
consuming to do. It seems possible that
many of those who completed the ques-
tionnaire would have taken greater care,
and achieved greater accuracy, if faced by a
real clinical situation. Nonetheless, for
those of us who are involved in training
clinical geneticists and genetic counsellors,
the article is a useful reminder of the
importance of this skill, and we will com-
municate with supervisors to reinforce the
importance of teaching Bayesian analysis to
our trainees.
Competing interests: None identified.
1 Bonke B, Tibben A, Lindhout D, et al. Genetic risk
estimation by healthcare professionals. Med J Aust
2005; 182: 116-118.  ❏
Benno Bonke,* Aad Tibben,† 
Dick Lindhout,‡ Angus J Clarke,§ 
Theo Stijnen¶
*Associate Professor, Department of Medical 
Psychology and Psychotherapy, Erasmus MC, 
PO Box 1738, Rotterdam, The Netherlands; 
†Professor, Department of Clinical Genetics and 
Neurology, Leiden University Medical Centre, Leiden, 
The Netherlands; ‡Professor, Department of Medical 
Genetics, University Medical Centre Utrecht, Utrecht, 
The Netherlands; §Professor, Department of Medical 
Genetics, University of Wales College of Medicine, 
Cardiff, UK; ¶Professor, Department of Epidemiology 
and Biostatistics, Erasmus MC. 
b.bonke@erasmusmc.nl
IN REPLY: Geneticists and counsellors must
be able to calculate risks according to pro-
fessional standards, regardless of whether
modified risks lead to decision changes.
Does training in genetic risk calculation
help? Only 21% of our respondents who
had had such training recently (<3 years
ago) estimated all target risks correctly. In
response to Kirk et al, calculating condi-
tional risks need not be time-consuming in
scenarios similar to our target pedigrees,1
and is often helpful when at-risk (grand)par-
ents do not wish to be tested but their
offspring do.
Given n children at 25% prior risk tested
negative and no other (grand)children
tested, the conditional risk for at-risk indi-
viduals in generation g (with g=0 at 50%
prior risk, g = 1 at 25% prior risk, etc) is
1/[2g(2n+1)]. Thus, in target #4 (n=1), the
father’s risk (g=0) equals 1/[2 0(21+1)]=
0.33. In target #9 (n=2), the unborn’ s risk
(g=2) equals 1/[22(22+1)]=0.05.
Similar formulas for more complicated
scenarios are available upon request. In cal-
culating risks, however, care must be taken
that the pedigrees and target individuals are
comparable to our scenarios. In target #7,
for instance, the risk for the untested aunt
does not increase simply because of the
decreased risk for her brother (gambler’s
fallacy).2
1 Bonke B, Tibben A, Lindhout D, et al. Genetic risk
estimation by healthcare professionals. Med J Aust
2005; 182: 116-118. 
2 Tversky A, Kahneman D. Judgment under uncer-
tainty: heuristics and biases. Science 1974; 185:
1124-1131. ❏
Is the Framingham coronary 
heart disease absolute risk 
function applicable to 
Aboriginal people?
Scott Kinlay
Director, Vascular Medicine and Endovascular 
Therapy, Veterans Affairs Medical Center and 
Brigham and Women’s Hospital, 75 Francis Street, 
Boston, MA 02115, USA.
skinlay@partners.org
TO THE EDITOR: Wang and Hoy1 deserve
much credit for highlighting yet again the
poor state of health of Indigenous Austral-
ians. However, their conclusion that the
Framingham equation underestimated risk
and that better prediction equations are
needed may miss the point.
The Framingham equations work well in
other populations if the aim is to rank
groups of individuals into higher or lower
risk categories. Box 4 in the article by Wang
and Hoy shows that they do this pretty well
across increasing age groups. Framingham
equations fall down when they are used to
estimate absolute risk in populations whose
coronary heart disease (CHD) rates are dif-
ferent from those in the Framingham study.
Some years ago, we showed that adjusting
Correspondence: Ms Sharmila Melvani and Professor Lindsay Grayson, Infectious Diseases Department,
Austin Health, 145 Studley Road, Heidelberg, VIC 3084. Sharmila.Melvani@austin.org.au
IDEA3S — the new electronic 
system to improve antibiotic 
prescribing
IDEA
3S, an infectious diseases electronic antibi-
otic advice and approval system, is now freely
available for download from the DeBug website at
http://www.debug.net.au/pharmacy/phar-
macy.html.
IDEA3S was developed to improve the appropri-
ateness of antibiotic use at Austin Health, Melbourne,
and to provide a simple audit tool for assessing quality
of antibiotic prescribing. The efficacy of this system was
described in our previous publication (Med J Aust 2004;
180: 455-458; available at: http://www.mja.com.au/public/
issues/180_09_030504/gra10569_fm.html).
The system provides electronic advice and approval for
high-cost antibiotics and those associated with clinically impor-
tant antibiotic resistance (eg, ceftriaxone and vancomycin), as well
as information on treating common pathogens. It incorporates
medical aid calculators (eg, pneumonia severity index and creatinine
clearance calculators) and PDF and HTML files for quick access to
pivotal publications and in-house guidelines and policies. In addition,
IDEA3S was designed to be either a stand-alone or multi-user application that
does not require Internet connection for its operation. Information content and
approval algorithms can be easily tailored to suit individual institutions.
As IDEA3S was developed with grant support from the Victorian and
Australian governments, we are able to provide IDEA3S free of charge. IDEA3S
can be a useful tool to improve antibiotic prescribing
in both urban and regional hospitals, especially those
with limited infectious diseases support.598 MJA • Volume 182 Number 11 • 6 June 2005
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the Framingham risk estimates in line with
the overall incidence of CHD in the popula-
tion modestly improved their performance.2
This is all very nice, but is better risk
estimation the solution? We don’t estimate
risk in other high-risk groups (eg, patients
with CHD), because all are at high risk and
all need risk factor reduction. A brief look at
the risk factor profile in Box 2 of Wang and
Hoy’s article reveals an alarming picture of
uncontrolled CHD risk factors in a relatively
young population (average age, 33–36
years). Cigarette smoking, dyslipidaemia,
diabetes and overweight prevail.
Perhaps, rather than concentrating on
quantifying the exact risk in such a high-risk
population, we should look at the reasons
for the high rates of risk factors. What
motivates some Indigenous people to smoke
more, be more overweight and have a higher
incidence of dyslipidaemia and diabetes
than other Australians?3,4 Do they feel dis-
enfranchised when governments infer they
are “dirty” by tying financial aid to face-
washing?5 Do they have attractive employ-
ment opportunities? Do they have enough
sense of control over their lives to reduce
their need to indulge in cigarettes and other
short-term pleasures? Are there adequate
supplies of healthy foods that they like?
These factors may differ, as some rural Abori-
ginal communities have much lower rates of
smoking, overweight and diabetes6 than
others. Exploring these issues will aid pre-
ventive methods aimed at the whole com-
munity.
In the meantime, I would suggest that the
Framingham equation does rank members
of this community — into modest, high,
and very high risk (the average 45–54-year-
old has a 20% risk of a CHD event over 10
years1). This may help guide the medical
treatment of risk factors and the pursuit of
the medical model of prevention while
social changes dictated by Aboriginal com-
munities take effect.
1 Wang Z, Hoy WE. Is the Framingham coronary heart
disease absolute risk function applicable to Aborig-
inal people? Med J Aust 2005; 182: 66-69. 
2 Kinlay S, O’Connell D, Evans D, Francis L. The
validity of estimating heart disease reduction from a
Framingham logistic equation. J Clin Epidemiol
1992; 45: 553-560.
3 Guest CS, O’Dea K, Larkins RG. Blood pressure,
lipids and other risk factors for cardiovascular dis-
ease in Aborigines and persons of European
descent of southeastern Australia. Aust J Public
Health 1994; 18: 79-86.
4 Thompson PL, Bradshaw PJ, Veroni M, Wilkes ET.
Cardiovascular risk among urban Aboriginal peo-
ple. Med J Aust 2003; 179: 143-146. 
5 Behrendt L. Nothing mutual about denying Aborig-
ines a voice. The Sydney Morning Herald 2004; 8
Dec : 13.
6 Gault A, O’Dea K, Rowley KG, et al. Abnormal
glucose tolerance and other coronary heart disease
risk factors in an isolated aboriginal community in
central Australia. Diabetes Care 1996; 19: 1269-
1273. ❏
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IN  REPLY: We agree with Kinlay that it is
important to prevent risk factors at the
population level (a population strategy).
However, there is also a need to properly
identify high-risk individuals who require
immediate medical intervention (a high-risk
strategy) and to understand the full spec-
trum of factors that determine such risk.
The primary focus of our study was to
assess whether the widely used Framingham
risk functions were applicable to Aboriginal
people in remote communities. Our data
show that the Framingham functions signif-
icantly underestimated the risk of coronary
heart disease (CHD).1 The high CHD risk in
Aboriginal people cannot be fully explained
by traditional risk factors. Some major risk
factors such as abnormal total cholesterol
level and obesity in the study population are
actually not as prevalent as those in the
general Australian population.2 Evaluation
of traditional risk factors and identification
of novel factors in this population are useful
for the development of intervention strat-
egies. Novel factors such as infection,
inflammation, albuminuria and low birth-
weight have been suggested as predictors of
CHD risk in this population.3,4
Kinlay suggests that Framingham func-
tions should be used to predict CHD risk in
Aboriginal people. We disagree. Guidelines
for the management of Aboriginal people
need to recognise the serious underestima-
tion of risk that the Framingham formulas
provide.
We agree that some high-risk groups, such
as patients with established CHD, do not need
additional risk estimates. With our current
knowledge, however, we can not say whether
the whole Aboriginal community should be
treated as a very high-risk population.
1 Wang Z, Hoy WE. Is the Framingham coronary heart
disease absolute risk function applicable to Aborig-
inal people? Med J Aust 2005; 182: 66-69. 
2 Wang Z, Hoy W. Hypertension, dyslipidaemia, body
mass index, diabetes and smoking status in Aborig-
inal Australians in a remote community. Ethn Dis
2003; 13: 324-330.
3 McDonald S, Maguire G, Duarte N, et al. C-reactive
protein, cardiovascular risk, and renal disease in a
remote Australian Aboriginal community. Clin Sci
2004; 106: 121-128.
4 Wang Z, Hoy W. Albuminuria and incident coronary
heart disease in Australian Aboriginal people. Kid-
ney Int 2005. In press. ❏
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TO THE EDITOR: We support the warning
of Talbot and colleagues regarding the ineq-
uities of the current system for provision of
bariatric surgery to the morbidly obese in
Australia.1
We recently analysed data on the
number of separations for bariatric surgery
for morbid obesity in Australia. The two
most common procedures in Australia are
gastric reduction surgery (procedure code
30511, which includes gastric stapling,
laparoscopic adjustable gastric banding
[LAGB] and gastroplasty) and gastric
bypass surgery (procedure code 30512).
The number of separations for procedure
30512 has remained quite stable and rela-
tively low (around 200 a year) over the past
few years. By contrast, the number of
separations for procedure 30511 has been
continually increasing. While the exact
number of LAGB procedures can not be
identified from this single code, it is
assumed that the majority of the increase is
due to LAGB, as it is a less invasive pro-
cedure and therefore generally more
acceptable to patients.2 However, the
number of separations for gastric reduction
surgery in public hospitals is low and has
Separations for all gastric reduction 
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remained so. In the financial year 2000–01
there were 1529 separations for gastric
reduction for morbid obesity across Aus-
tralia, only 194 (13%) of which were per-
formed in public hospitals (see Box). In
2001–02 the total number increased to
2351, but the number performed in public
hospitals increased only marginally, to 238
(10% of the overall number). In 2002–03,
the last year of available data, there were
2612 separations, of which only 287 (11%)
were performed in public hospitals
(unpublished data, courtesy of the Austral-
ian Institute of Health and Welfare).
Clearly, if this issue is not addressed sys-
tematically, it will only serve to widen the
socioeconomic inequalities in health associ-
ated with obesity in Australia.
Acknowledgements: All data were provided by the
Australian Institute of Health and Welfare. Anna
Peeters is a VicHealth Research Fellow.
Competing interests: Paul O’Brien is a bariatric
surgeon who receives research funding from
Inamed Health Corporation, manufacturers of the
Bioenterics Lap Band. Inamed Health Corporation
had no involvement in writing or submitting this
letter.
1 Talbot ML, Jorgensen JO, Loi KW. Difficulties in
provision of bariatric surgical services to the mor-
bidly obese. Med J Aust 2005; 182: 344-347. 
2 Medical Services Advisory Committee. Laparo-
scopic adjustable gastric banding for morbid obes-
ity. Canberra: Australian Department of Health and
Ageing, 2003. (MSAC Reference 14.) ❏
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TO  THE E DITOR:  The recent article by
Willcock and colleagues on the high psy-
chological morbidity and level of burnout
that interns experience during their first
year in hospital  highlights an important
topic.1
Willcock et al point out that there is an
increase in psychiatric morbidity over the
intern period in first-year medical gradu-
ates. This corroborates the findings of a
larger study we conducted among interns
during their first year, in which we showed
that psychiatric morbidity rises, particu-
larly during the middle of this first year as
a doctor, but then decreases by the end of
the year.2
The point made by Willcock et al1 is that
psychiatric morbidity is not limited to first
year graduates — senior doctors are also
susceptible to psychological morbidity and
burnout.3
Their article highlights the continuing
need for workplace reform and support for
the medical profession. In addition to
reducing working hours, other interven-
tions need to be considered to prepare
medical students for their profession, and
to reduce the factors which contribute to
morbidity (eg, workload, multiple tasking,
incessant paging). It should be feasible to
test the efficacy of such interventions with
the same instruments (such as the General
Health Questionnaire) in future genera-
tions of interns, and to compare these
results with the above studies. Showing
that such interventions are effective will
provide a strong platform from which to
implement wider change in the workplace.
1 Willcock SM, Daly MG, Tennant CC, Allard BJ.
Burnout and psychiatric morbidity in new medical
graduates. Med J Aust 2004; 181: 357-360. 
2 Bruce C, Thomas PS, Yates DH. Health and stress
in Australian interns. Intern Med J 2003; 33: 392-
395.
3 Bruce CT, Sanger MM, Thomas PS, et al. Factors
affecting female or male consultant stress in an
Australian teaching hospital [letter]. Med J Aust
2003; 179: 174-175.  ❏
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IN REPLY: Bruce and colleagues are correct
to call for ongoing workplace reform and
support for the medical profession in gen-
eral. Our study, which followed medical
students to the end of their intern year, did
not show a significant fall in psychiatric
morbidity towards the end of the intern year
as theirs did. Our review of the recent
literature suggests that any “improvement”
in psychological morbidity after the mid-
year peak during internship is likely to be
transient, with the early postgraduate period
representing a period of transition from
normative population values of burnout and
morbidity to levels which remain high
throughout a medical career, when com-
pared with the general population.
The traditional interpretation of the
internship as a “baptism by fire”, which tests
and ultimately strengthens the new medical
graduate, does not hold up to scrutiny. A
realistic assessment of this period suggests
that it is one where stress and distress often
reach unhealthy levels, and where dysfunc-
tional coping strategies may be developed
which persist throughout a medical career.
The development of mature personal cop-
ing strategies along with systemic changes to
promote engagement with work have been
identified as the most likely means of limit-
ing burnout and its sequelae among medical
practitioners.1
1 Maslach C, Schaufeli WB, Leiter MP. Job burnout.
Ann Rev Psychol 2001; 52: 397-422. ❏
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TO  THE E DITOR:  McGrath’s article on
integrating overseas-trained doctors (OTDs)
into the Australian medical workforce noted
that the areas of difficulty in this area have
been well defined.1 McGrath challenged us
to “get on with it”. We interpret this chal-
lenge to mean that there has been enough
regurgitating and redefining of the problem,
and it is time for some action.
In South Australia, the difficulties of inte-
grating overseas doctors into the workforce
mirror those experienced by other states.
The Department of Health Overseas Trained
Doctor 2004 database listed 93 OTDs as
eligible to work in SA. Seventy were
employed. All of these doctors had only
completed the Australian Medical Council
(AMC) Multiple Choice Question (MCQ)
examination. Since its inception in April
2003, the Postgraduate Medical Council of
South Australia (PMCSA) AMC doctors sub-
committee has worked to put in place a
number of educational initiatives to support
and assist OTDs to complete the Australian
Medical Council Exams, and to advocate for
their ongoing needs for better orientation to
the workplace and protected education time
at work.
The programs initiated by the PMCSA are
both Government-funded and self-funded.
They are: culture and medical communica-
tion for doctors, MCQ tutorial program,
ready for work program, hospital tutorials,600 MJA • Volume 182 Number 11 • 6 June 2005
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objective structured clinical examination
practice exam, clinical bridging program,
and study groups.
Examination results in 2004 for candi-
dates undertaking the PMCSA programs
bettered the national average. Of the 16
enrolled participants in the MCQ tutorial
program, which ran from January to April
2004, nine sat the May AMC MCQ exam
and seven deferred. Eight of the nine passed,
giving a pass rate of 89% (AMC pass rate
56%; Australian Medical Council, personal
communication).
In the AMC clinical examinations, our
candidates achieved an overall pass rate of
67%; 30 sat the exam, 20 passed and 10
were given a re-sit or a fail result. (AMC pass
rate 59%; Examinations Officer Clinical,
Australian Medical Council, personal com-
munication). Twenty chose to defer after
using the various programs and tutorials on
offer to gauge their level of preparedness.
These doctors are planning to undertake the
exam in 2005.
These programs constitute the South Aus-
tralian Action Plan for OTD inclusion in the
workforce.2 All of these programs are avail-
able and appropriate for any OTD (perma-
nent resident or temporary resident). To the
best of our knowledge, no temporary resi-
dent wishing to work in “areas of need” has
enrolled in our programs yet.
1 McGrath BP. Integration of overseas-trained doc-
tors into the Australian medical workforce. Med J
Aust 2004; 181: 640-642. 
2 Hart LS, Vernon-Roberts J. South Australian action
plan for OTD inclusion in the Australian medical
workforce. Adelaide: Postgraduate Medical Council
South Australia, 2005. ❏
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IN REPLY: Hart and Vernon-Roberts outline
the South Australian Action Plan by the
Postgraduate Medical Council of South Aus-
tralia Australian Medical Council (AMC)
doctors subcommittee to support and assist
overseas trained doctors (OTDs). Their wor-
thy efforts are directed predominantly
towards the many OTDs preparing for their
AMC examinations, with associated bridg-
ing and “ready-for-work” programs to facili-
tate entry into the hospital medical
workforce.
However, the question that needs to be
addressed, and which was the main thrust of
my article,1 is why we don’t have a national
coordinated approach to all elements of the
pathway to integrating OTDs into the Aus-
tralian health care system. This cannot be a
largely political approach, as is the Austral-
ian Government’s Strengthening Medicare
initiative, which is particularly weak in the
areas of assessment for safe practice and
support in training.
A recent article has highlighted the need
for a national approach to coordinated gov-
ernance for postgraduate medical education
in Australia and the unsatisfactory complex-
ity of medical education and training sys-
tems in this country.2 This excellent article
includes only very brief reference to OTDs,
using the term “international medical gradu-
ates”,2 which is becoming the more accept-
able term and the one recognised by other
countries. It does not address the many gaps
and problems in the pathways for this
group.
The number of international medical
graduates seeking employment and/or being
actively recruited into the medical work-
force in Australia each year is far greater
than the number graduating from our own
medical schools. Thus, there is a degree of
urgency about the debate on postgraduate
medical education in Australia. We need a
national authoritative body, like the new
United Kingdom Postgraduate Medical Edu-
cation and Training Board.
1 McGrath BP. Integration of overseas-trained doc-
tors into the Australian medical workforce. Med J
Aust 2004; 181: 640-642. 
2 Dowton B, Stokes M-L, Rawstron E, et al. Postgrad-
uate medical education: rethinking and integrating
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